• 50 Citations
  • 4 h-Index
20112019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Nicole Rich is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 15 Similar Profiles
Hepatocellular Carcinoma Medicine & Life Sciences
Hepacivirus Medicine & Life Sciences
Eyelids Medicine & Life Sciences
Antiviral Agents Medicine & Life Sciences
Survival Medicine & Life Sciences
Alcoholic Hepatitis Medicine & Life Sciences
Lacrimal Apparatus Medicine & Life Sciences
Fibrin Tissue Adhesive Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2011 2019

  • 50 Citations
  • 4 h-Index
  • 8 Article
  • 1 Editorial
  • 1 Review article
1 Citation (Scopus)
Open Access
Hepatitis
Liver Diseases
Hepatocellular Carcinoma
Alcohols
Hepatitis B virus
2 Citations (Scopus)

Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma

Singal, A. G., Rich, N. E., Mehta, N., Branch, A. D., Pillai, A., Hoteit, M., Volk, M., Odewole, M., Scaglione, S., Guy, J., Said, A., Feld, J. J., John, B. V., Frenette, C., Mantry, P., Rangnekar, A. S., Oloruntoba, O., Leise, M., Jou, J. H., Bhamidimarri, K. R. & 17 others, Kulik, L., Ioannou, G. N., Huang, A., Tran, T., Samant, H., Dhanasekaran, R., Duarte-Rojo, A., Salgia, R., Eswaran, S., Jalal, P., Flores, A., Satapathy, S. K., Kagan, S., Gopal, P., Wong, R., Parikh, N. D. & Murphy, C. C., Nov 2019, In : Gastroenterology. 157, 5, p. 1253-1263.e2

Research output: Contribution to journalArticle

Virus Diseases
Hepacivirus
Antiviral Agents
Hepatocellular Carcinoma
Survival
20 Citations (Scopus)

Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study

Singal, A. G., Rich, N. E., Mehta, N., Branch, A., Pillai, A., Hoteit, M., Volk, M., Odewole, M., Scaglione, S., Guy, J., Said, A., Feld, J. J., John, B. V., Frenette, C., Mantry, P., Rangnekar, A. S., Oloruntoba, O., Leise, M., Jou, J. H., Bhamidimarri, K. R. & 27 others, Kulik, L., Tran, T., Samant, H., Dhanasekaran, R., Duarte-Rojo, A., Salgia, R., Eswaran, S., Jalal, P., Flores, A., Satapathy, S. K., Wong, R., Huang, A., Misra, S., Schwartz, M., Mitrani, R., Nakka, S., Noureddine, W., Ho, C., Konjeti, V. R., Dao, A., Nelson, K., Delarosa, K., Rahim, U., Mavuram, M., Xie, J. J., Murphy, C. C. & Parikh, N. D., May 1 2019, In : Gastroenterology. 156, 6, p. 1683-1692.e1

Research output: Contribution to journalArticle

Antiviral Agents
Hepatocellular Carcinoma
Cohort Studies
Recurrence
Therapeutics

Editorial: liver test abnormalities in oncology patients in the age of the checkpoint inhibitors

Rich, N. E. & Lee, W. M., Oct 1 2019, In : Alimentary Pharmacology and Therapeutics. 50, 7, p. 831-832 2 p.

Research output: Contribution to journalEditorial

Open Access
Liver
1 Citation (Scopus)
Hepatocellular Carcinoma
Survival
Neoplasms
Therapeutics
Confidence Intervals